$MASI
MASIMO CORP

2016 Q3 Form 10-Q Financial Statement

#000093755617000193 Filed on August 02, 2017

View on sec.gov

Income Statement

Concept 2016 Q3
Revenue $172.6M
YoY Change 10.86%
Cost Of Revenue $57.50M
YoY Change 8.85%
Gross Profit $115.1M
YoY Change 11.89%
Gross Profit Margin 66.69%
Selling, General & Admin $63.89M
YoY Change 3.6%
% of Gross Profit 55.49%
Research & Development $14.82M
YoY Change 10.63%
% of Gross Profit 12.87%
Depreciation & Amortization $4.000M
YoY Change 2.56%
% of Gross Profit 3.47%
Operating Expenses $78.71M
YoY Change 4.86%
Operating Profit $36.43M
YoY Change 30.85%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $471.0K
YoY Change -141.87%
Pretax Income $36.90M
YoY Change 38.12%
Income Tax $6.877M
% Of Pretax Income 18.64%
Net Earnings $30.02M
YoY Change 55.15%
Net Earnings / Revenue 17.39%
Basic Earnings Per Share $0.61
Diluted Earnings Per Share $0.57
COMMON SHARES
Basic Shares Outstanding 49.26M shares
Diluted Shares Outstanding 52.70M shares

Balance Sheet

Concept 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $116.1M
YoY Change -2.76%
Cash & Equivalents $116.1M
Short-Term Investments
Other Short-Term Assets $23.00M
YoY Change 12.37%
Inventory $62.31M
Prepaid Expenses $13.17M
Receivables $84.81M
Other Receivables $300.0K
Total Short-Term Assets $296.0M
YoY Change -4.41%
LONG-TERM ASSETS
Property, Plant & Equipment $133.0M
YoY Change 8.4%
Goodwill $20.38M
YoY Change 0.08%
Intangibles $28.26M
YoY Change 0.81%
Long-Term Investments
YoY Change
Other Assets $12.26M
YoY Change -3.25%
Total Long-Term Assets $306.7M
YoY Change 11.95%
TOTAL ASSETS
Total Short-Term Assets $296.0M
Total Long-Term Assets $306.7M
Total Assets $602.7M
YoY Change 3.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.71M
YoY Change -5.41%
Accrued Expenses $26.78M
YoY Change -4.96%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $100.0K
YoY Change 0.0%
Total Short-Term Liabilities $120.4M
YoY Change 5.38%
LONG-TERM LIABILITIES
Long-Term Debt $175.0M
YoY Change -1.46%
Other Long-Term Liabilities $30.00K
YoY Change -99.59%
Total Long-Term Liabilities $30.00K
YoY Change -99.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $120.4M
Total Long-Term Liabilities $30.00K
Total Liabilities $307.5M
YoY Change 2.67%
SHAREHOLDERS EQUITY
Retained Earnings $346.2M
YoY Change 41.21%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $404.3M
YoY Change 51.07%
Treasury Stock Shares 14.26K shares
Shareholders Equity $295.1M
YoY Change
Total Liabilities & Shareholders Equity $602.7M
YoY Change 3.27%

Cashflow Statement

Concept 2016 Q3
OPERATING ACTIVITIES
Net Income $30.02M
YoY Change 55.15%
Depreciation, Depletion And Amortization $4.000M
YoY Change 2.56%
Cash From Operating Activities $37.90M
YoY Change 298.95%
INVESTING ACTIVITIES
Capital Expenditures -$6.000M
YoY Change -36.17%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$5.900M
YoY Change -37.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -54.70M
YoY Change 223.67%
NET CHANGE
Cash From Operating Activities 37.90M
Cash From Investing Activities -5.900M
Cash From Financing Activities -54.70M
Net Change In Cash -22.70M
YoY Change 35.12%
FREE CASH FLOW
Cash From Operating Activities $37.90M
Capital Expenditures -$6.000M
Free Cash Flow $43.90M
YoY Change 132.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-07-01
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000937556
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51940147 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
MASIMO CORP
dei Trading Symbol
TradingSymbol
MASI
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1168000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2113000 USD
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P10Y
masi Percentage Of Revenue Two Customer
PercentageOfRevenueTwoCustomer
0.119
CY2016Q4 masi Accrued Donations Current
AccruedDonationsCurrent
503000 USD
CY2017Q3 masi Accrued Donations Current
AccruedDonationsCurrent
493000 USD
CY2016Q4 masi Accruedcustomerrebatesfeesandreimbursement
Accruedcustomerrebatesfeesandreimbursement
3893000 USD
CY2017Q3 masi Accruedcustomerrebatesfeesandreimbursement
Accruedcustomerrebatesfeesandreimbursement
4225000 USD
CY2016Q4 masi Concentration Risk Longlived Asset Geographic Area Percentage
ConcentrationRiskLonglivedAssetGeographicAreaPercentage
1.000
CY2017Q3 masi Concentration Risk Longlived Asset Geographic Area Percentage
ConcentrationRiskLonglivedAssetGeographicAreaPercentage
1.000
masi Deconsolidation Variable Interest Entity Reductionof Cash
DeconsolidationVariableInterestEntityReductionofCash
-763000 USD
masi Deconsolidation Variable Interest Entity Reductionof Cash
DeconsolidationVariableInterestEntityReductionofCash
0 USD
CY2017Q3 masi Estimateof Annual Preventable Hospital Deaths Preventedby2020
EstimateofAnnualPreventableHospitalDeathsPreventedby2020
200000 death
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1400000 shares
masi Numberof Sourcesof Product Revenue
NumberofSourcesofProductRevenue
4 segment
CY2016Q3 masi Percentage Of Revenue One Customer
PercentageOfRevenueOneCustomer
0.148
masi Percentage Of Revenue One Customer
PercentageOfRevenueOneCustomer
0.154
CY2017Q3 masi Percentage Of Revenue One Customer
PercentageOfRevenueOneCustomer
0.133
masi Percentage Of Revenue One Customer
PercentageOfRevenueOneCustomer
0.137
CY2016Q3 masi Percentage Of Revenue Two Customer
PercentageOfRevenueTwoCustomer
0.127
CY2017Q3 masi Royalty
Royalty
10131000 USD
masi Royalty
Royalty
18336000 USD
CY2016Q4 masi Royalty Receivable
RoyaltyReceivable
7500000 USD
CY2007Q1 masi Numberof Companieswith Rightsto Intellectual Property
NumberofCompanieswithRightstoIntellectualProperty
2 company
CY2014Q1 masi Numberof Participantsinthe Surfactant Positive Pressureand Oxygenation Randomized Trial
NumberofParticipantsintheSurfactantPositivePressureandOxygenationRandomizedTrial
2 participant
CY2017Q3 masi Percentage Of Revenue Two Customer
PercentageOfRevenueTwoCustomer
0.113
masi Percentage Of Revenue Two Customer
PercentageOfRevenueTwoCustomer
0.117
masi Proceedsfromstockoptionsexercisedunsettledatperiodend
Proceedsfromstockoptionsexercisedunsettledatperiodend
187000 USD
masi Proceedsfromstockoptionsexercisedunsettledatperiodend
Proceedsfromstockoptionsexercisedunsettledatperiodend
237000 USD
masi Property Plantand Equipment Occupied Square Feet
PropertyPlantandEquipmentOccupiedSquareFeet
16830 sqft
CY2016Q3 masi Royalty
Royalty
8029000 USD
masi Royalty
Royalty
15906000 USD
CY2017Q3 masi Royalty Receivable
RoyaltyReceivable
8000000 USD
masi Royalty Revenue Numberof Days Royalty Revenueis Adjusted Subsequentto Quarter End
RoyaltyRevenueNumberofDaysRoyaltyRevenueisAdjustedSubsequenttoQuarterEnd
P60D
CY2017Q3 masi Severance Plan Participation Agreements
SeverancePlanParticipationAgreements
6 Agreement
masi Supplemental Unemployment Benefits Severance Benefits Required Noticeof Resignation
SupplementalUnemploymentBenefitsSeveranceBenefitsRequiredNoticeofResignation
P6M
CY2016Q4 masi Unrecognized Tax Benefits Liabilities Noncurrent
UnrecognizedTaxBenefitsLiabilitiesNoncurrent
13442000 USD
CY2017Q3 masi Unrecognized Tax Benefits Liabilities Noncurrent
UnrecognizedTaxBenefitsLiabilitiesNoncurrent
14308000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
34334000 USD
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
38270000 USD
CY2016Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
10673000 USD
CY2017Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
14522000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
101667000 USD
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
104159000 USD
CY2016Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
77000 USD
CY2017Q3 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
21000 USD
CY2016Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
5135000 USD
CY2017Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
4205000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
104654000 USD
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
36677000 USD
CY2016Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
1362000 USD
CY2017Q3 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
1510000 USD
CY2016Q4 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
700000 USD
CY2017Q3 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
1400000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
68233000 USD
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
75268000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-7027000 USD
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-4161000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2016Q4 us-gaap Assets
Assets
820525000 USD
CY2017Q3 us-gaap Assets
Assets
895668000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
507227000 USD
CY2017Q3 us-gaap Assets Current
AssetsCurrent
565994000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
382263000 USD
CY2017Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
436549000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1698 USD
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1460 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1800000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2500000 USD
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1600000 shares
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
2000 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
0 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
0 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
0 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
0 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
100000 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
2000 USD
CY2017Q3 us-gaap Cash
Cash
331400000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
132317000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
116055000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
305970000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
331448000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-16262000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
25478000 USD
CY2017Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
3100000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14500000 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50188 shares
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51940 shares
CY2016Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
50000 USD
CY2017Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
52000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
28814000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
57790000 USD
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
57501000 USD
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
48980000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
94880000 USD
CY2016Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000
CY2017Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000
CY2017Q3 us-gaap Contractual Obligation
ContractualObligation
27161000 USD
CY2017Q3 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
7169000 USD
CY2017Q3 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
2526000 USD
CY2017Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
3057000 USD
CY2017Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
6017000 USD
CY2017Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
5260000 USD
CY2017Q3 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
3132000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
114455000 USD
CY2017Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
64496000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
126664000 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
273000 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
CY2016Q2 us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
0.3 USD
CY2016Q4 us-gaap Deferred Costs
DeferredCosts
79948000 USD
CY2017Q3 us-gaap Deferred Costs
DeferredCosts
93936000 USD
CY2016Q4 us-gaap Deferred Credits And Other Liabilities
DeferredCreditsAndOtherLiabilities
14587000 USD
CY2017Q3 us-gaap Deferred Credits And Other Liabilities
DeferredCreditsAndOtherLiabilities
16268000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5001000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
558000 USD
CY2017Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1328000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
38198000 USD
CY2017Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
38526000 USD
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
25336000 USD
CY2017Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
24652000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
38975000 USD
CY2017Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
39012000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
340000 USD
CY2017Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
339000 USD
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.03
us-gaap Depreciation
Depreciation
6300000 USD
us-gaap Depreciation
Depreciation
7000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8132000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9462000 USD
CY2016Q4 us-gaap Due From Employees Current
DueFromEmployeesCurrent
305000 USD
CY2017Q3 us-gaap Due From Employees Current
DueFromEmployeesCurrent
325000 USD
CY2016Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
525000 USD
CY2017Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
670000 USD
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-196000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.80
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1825000 USD
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.90
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.10
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.17
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4703000 shares
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
297000 USD
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
43180000 USD
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
31871000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21313000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23060000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
8884000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5244000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2482000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3259000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3574000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4656000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
50689000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
51159000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
29376000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28099000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-401000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-365000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
19780000 USD
CY2017Q3 us-gaap Goodwill
Goodwill
20388000 USD
CY2016Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2017Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2016Q3 us-gaap Gross Profit
GrossProfit
115135000 USD
us-gaap Gross Profit
GrossProfit
229348000 USD
CY2017Q3 us-gaap Gross Profit
GrossProfit
128437000 USD
us-gaap Gross Profit
GrossProfit
252571000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
36900000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
74735000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
47026000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
91095000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6877000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17135000 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
346000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-919000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
19292000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
81662000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7943000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3139000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3739000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2094000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-13807000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-67641000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1566000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
13700000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5263000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
327000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15554000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
7462000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3937000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-11679000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
969000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
14694000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
6596000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1288000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3875000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
985000 USD
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3447000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3064000 shares
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4496000 shares
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29376000 USD
CY2017Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28099000 USD
us-gaap Interest Paid Net
InterestPaidNet
2603000 USD
us-gaap Interest Paid Net
InterestPaidNet
321000 USD
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
32194000 USD
CY2017Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
39141000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
72542000 USD
CY2017Q3 us-gaap Inventory Net
InventoryNet
88458000 USD
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
32647000 USD
CY2017Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
42562000 USD
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
7701000 USD
CY2017Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6755000 USD
CY2016Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1600000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3100000 USD
CY2017Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1600000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3200000 USD
CY2017Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
300000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
260289000 USD
CY2017Q3 us-gaap Liabilities
Liabilities
186264000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
820525000 USD
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
895668000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
220366000 USD
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
145344000 USD
CY2017Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-59911000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
48148000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12846000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10086000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
56691000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14409000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
30023000 USD
us-gaap Net Income Loss
NetIncomeLoss
57600000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
46680000 USD
us-gaap Net Income Loss
NetIncomeLoss
92014000 USD
CY2016Q4 us-gaap Noncurrent Assets
NoncurrentAssets
225167000 USD
CY2017Q3 us-gaap Noncurrent Assets
NoncurrentAssets
242175000 USD
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
606000 USD
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-40000 USD
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
471000 USD
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-5000 USD
us-gaap Product Warranty Expense
ProductWarrantyExpense
488000 USD
us-gaap Product Warranty Expense
ProductWarrantyExpense
485000 USD
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
158000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1032000 USD
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
78706000 USD
us-gaap Operating Expenses
OperatingExpenses
155582000 USD
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
81569000 USD
us-gaap Operating Expenses
OperatingExpenses
162508000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
36429000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
73766000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
46868000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
90063000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
27159000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2526000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3057000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
5260000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
6017000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
7169000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
3130000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5337000 USD
CY2017Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5178000 USD
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
27048000 USD
CY2017Q3 us-gaap Other Assets Current
OtherAssetsCurrent
41929000 USD
CY2016Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
5134000 USD
CY2017Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
4149000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9223000 USD
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10516000 USD
CY2017Q3 us-gaap Other Commitment
OtherCommitment
300000 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1209000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
190000 USD
CY2017Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2300000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2866000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
247000 USD
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
293000 USD
us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
5100000 USD
us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
30200000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
68218000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
621000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1349000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1574000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10734000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8512000 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2017Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13051000 USD
CY2017Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12941000 USD
CY2017Q3 us-gaap Prepaid Taxes
PrepaidTaxes
16493000 USD
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Prepaid Taxes
PrepaidTaxes
981000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.010
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
45000000 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18997000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
48218000 USD
CY2016Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1222000 USD
CY2016Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1215000 USD
CY2016Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
910000 USD
CY2017Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1026000 USD
CY2016Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
910000 USD
CY2017Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1026000 USD
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
521000 USD
CY2016Q3 us-gaap Profit Loss
ProfitLoss
30023000 USD
us-gaap Profit Loss
ProfitLoss
57600000 USD
CY2017Q3 us-gaap Profit Loss
ProfitLoss
46680000 USD
us-gaap Profit Loss
ProfitLoss
92014000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
204229000 USD
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
212991000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
135996000 USD
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
137723000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-51000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-193000 USD
CY2017Q3 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
77900000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
55000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
69000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
70000 USD
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14818000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29183000 USD
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15192000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30559000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
589226000 USD
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
681240000 USD
CY2016Q3 us-gaap Revenues
Revenues
172636000 USD
us-gaap Revenues
Revenues
343803000 USD
CY2017Q3 us-gaap Revenues
Revenues
192933000 USD
us-gaap Revenues
Revenues
379235000 USD
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
164607000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
327897000 USD
CY2017Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
182802000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
360899000 USD
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
63888000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
126399000 USD
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
66377000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
131949000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6204000 USD
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation
ShareBasedCompensation
6142000 USD
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.356
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.374
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.319
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.357
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.323
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.320
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.303
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.303
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.018
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.019
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.013
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.019
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.015
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.013
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.010
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
4600000 shares
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4082000 shares
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
26.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
108600000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
109000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
281000 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.24
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
28.58
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
27.82
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
417000000 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8521000 shares
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6948000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
28.56
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.19
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
264400000 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
27.58
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
32.03
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
88.64
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
6200000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
6100000 USD
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M12D
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1745000 shares
CY2015Q3 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
5000000.0 shares
CY2017Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
2900000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
560236000 USD
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
709404000 USD
CY2016Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
76316000 USD
CY2017Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
4848000 USD
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
14255 shares
CY2017Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
14255 shares
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
404276000 USD
CY2017Q3 us-gaap Treasury Stock Value
TreasuryStockValue
404276000 USD
CY2017Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
15300000 USD
CY2017Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
13800000 USD
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52703000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52404000 shares
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56173000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55867000 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49256000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49340000 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51677000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51164000 shares
us-gaap Fiscal Period
FiscalPeriod
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Periods</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company follows a conventional 52/53 week fiscal year. Under a conventional 52/53 week fiscal year, a 52 week fiscal year includes four quarters of 13 fiscal weeks while a 53 week fiscal year includes three 13 fiscal week quarters and one 14 fiscal week quarter. The Company&#8217;s last 53 week fiscal year was fiscal year 2014. Fiscal year </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> is a 52 week fiscal year. All references to years in these notes to condensed consolidated financial statements are fiscal years unless otherwise noted.</font></div></div>
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Description of the Company</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Masimo Corporation (the Company) is a global medical technology company that develops, manufactures and markets a variety of noninvasive patient monitoring technologies. The Company&#8217;s mission is to improve patient outcomes and reduce cost of care by taking noninvasive monitoring to new sites and applications</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. The Company&#8217;s patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The Company primarily sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long term care facilities and consumers through its direct sales force, distributors and original equipment manufacturer (OEM) partners.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company invented Masimo Signal Extraction Technology</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt"> </sup></font><font style="font-family:inherit;font-size:10pt;">(SET</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">), which provides the capabilities of </font><font style="font-family:inherit;font-size:10pt;">Measure-through Motion and Low Perfusion</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#8482;</sup></font><font style="font-family:inherit;font-size:10pt;"> pulse oximetry to address the primary limitations of conventional pulse oximetry. Over the years, the Company&#8217;s product offerings have expanded significantly to also include noninvasive optical blood constituent monitoring, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and optical gas monitoring. The Company also developed the Root</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> patient monitoring and connectivity platform and the Masimo Patient SafetyNet</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font><font style="font-family:inherit;font-size:10pt;"> remote patient surveillance monitoring system. These solutions and related products are based upon Masimo SET</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, rainbow</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and other proprietary algorithms. These software-based technologies are incorporated into a variety of product platforms depending on customers&#8217; specifications. In addition, these technologies are supported by a substantial intellectual property portfolio that the Company has built through internal development, acquisitions and license agreements.</font></div></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-align:left;padding-left:18px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications</font><font style="font-family:inherit;font-size:12pt;"> </font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts in the accompanying condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. </font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:8pt;"></font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;padding-top:17px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company prepares its financial statements in conformity with GAAP, which requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates include the determination of accounts receivable allowances, inventory reserves, warranty reserves, rebate accruals, valuation of the Company&#8217;s stock options, goodwill valuation, deferred taxes and any associated valuation allowances, distributor channel inventory, royalty revenues, deferred revenue, uncertain income tax positions, litigation costs and related accruals. Actual results could differ from such estimates.</font></div><div style="line-height:120%;padding-top:17px;text-align:left;padding-left:18px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font></div></div>

Files In Submission

Name View Source Status
0000937556-17-000193-index-headers.html Edgar Link pending
0000937556-17-000193-index.html Edgar Link pending
0000937556-17-000193.txt Edgar Link pending
0000937556-17-000193-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
masi-20170701.xml Edgar Link completed
masi-20170701.xsd Edgar Link pending
masi-20170701x10q.htm Edgar Link pending
masi-20170701x10qex121.htm Edgar Link pending
masi-20170701x10qex211.htm Edgar Link pending
masi-20170701x10qex311.htm Edgar Link pending
masi-20170701x10qex312.htm Edgar Link pending
masi-20170701x10qex321.htm Edgar Link pending
masi-20170701_cal.xml Edgar Link unprocessable
masi-20170701_def.xml Edgar Link unprocessable
masi-20170701_lab.xml Edgar Link unprocessable
masi-20170701_pre.xml Edgar Link unprocessable
masimologoq32016-01a02.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending